Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.78 |
| ▸ | RNASEL | Q05823 | 4/20 | 0.65 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.64 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.64 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.60 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | NT5E | P21589 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | HINT1 | P49773 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29936666 | 1.00 | ADORA3 (0.78) | ADORA3RNASELADORA2AADORA2BDNMT1 | |
| SCHEMBL4454099 | 0.90 | ADORA3 (0.80) | ADORA3ADORA2AADORA2BADORA1CA1 | |
| SCHEMBL1938203 | 0.90 | ADORA3 (0.80) | ADORA3ADORA2AADORA2BADORA1CA1 | |
| SCHEMBL12443734 | 0.90 | ADORA3 (0.80) | ADORA3ADORA2AADORA2BADORA1CA1 | |
| SCHEMBL13524754 | 0.88 | ADORA3 (0.77) | ADORA3ADORA2AADORA2BDNMT1DNMT3B | |
| SCHEMBL4457018 | 0.88 | ADORA3 (0.77) | ADORA3ADORA2AADORA2BDNMT1DNMT3B | |
| SCHEMBL4451649 | 0.88 | ADORA3 (1.00) | ADORA3ADORA2AADORA2BADORA1CA1 | |
| SCHEMBL4451640 | 0.88 | ADORA3 (1.00) | ADORA3ADORA2AADORA2BADORA1CA1 | |
| SCHEMBL4457021 | 0.88 | ADORA3 (0.77) | ADORA3ADORA2AADORA2BDNMT1DNMT3B | |
| SCHEMBL10459402 | 0.88 | ADORA3 (0.77) | ADORA3ADORA2AADORA2BDNMT1ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3212201-B1 | NUCLEOSIDE KINASE INHIBITORS | BCI PHARMA (FR) | 2022-10-19 | — | — | EP | claimed |
| WO-2024112568-A1 | ANTISENSE OLIGOMER (ASO) AS AN INHIBITOR OF LIVER FIBROSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-05-30 | — | — | WO | disclosed |
| WO-2023014974-A1 | DOUBLE STRANDED MRNA VACCINES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2023-02-09 | — | — | WO | disclosed |
| EP-3212201-B1 | NUCLEOSIDE KINASE INHIBITORS | BCI PHARMA (FR) | 2022-10-19 | — | — | EP | disclosed |
| EP-3864156-A1 | PLASMID CONTAINING A SEQUENCE ENCODING AN MRNA WITH A SEGMENTED POLY(A) TAIL | ethris GmbH (DE) | 2021-08-18 | — | — | EP | disclosed |
| US-20210236533-A1 | METABOLICALLY STABILIZED DOUBLE STRANDED mRNA | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2021-08-05 | — | — | US | disclosed |
| EP-3852814-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | ModernaTX, Inc. (US) | 2021-07-28 | — | — | EP | disclosed |
| US-11007213-B2 | Metabolically stabilized double stranded mRNA | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2021-05-18 | — | — | US | disclosed |
| WO-2020061397-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | MODERNATX, INC. (US) | 2020-03-26 | — | — | WO | disclosed |
| US-20190111070-A1 | METABOLICALLY STABILIZED DOUBLE STRANDED mRNA | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2019-04-18 | — | — | US | disclosed |
| WO-2015196118-A1 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS, INC. (US) | 2015-12-23 | — | — | WO | disclosed |
| EP-2931319-A1 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | Moderna Therapeutics, Inc. (US) | 2015-10-21 | — | — | EP | disclosed |
| WO-2015089511-A2 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS, INC. (US) | 2015-06-18 | — | — | WO | disclosed |
| WO-2015051173-A2 | POLYNUCLEOTIDE MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS, INC (US) | 2015-04-09 | — | — | WO | disclosed |
| WO-2014093924-A1 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS, INC. (US) | 2014-06-19 | — | — | WO | disclosed |
| US-5773603-A | ADENOSINE DEAMINASE INHIBITOR | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1998-06-30 | — | — | US | disclosed |
| US-5705491-A | Adenosine deaminase inhibitor | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1998-01-06 | — | — | US | disclosed |
| EP-0601322-A2 | Adenosindeaminase inhibitor | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1994-06-15 | — | — | EP | disclosed |
| EP-0269574-B1 | NOVEL ADENOSINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS AN ACTIVE INGREDIENT | NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) | 1992-03-18 | — | — | EP | disclosed |
| US-4843066-A | HYPOTENSIVE AGENTS | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1989-06-27 | — | — | US | disclosed |